Homepage > Company > Media > Pharma News > 2020 > U.S. Health Secretary Says at Least 40 Labs Can Currently Test for Coronavirus

U.S. Health Secretary Says at Least 40 Labs Can Currently Test for Coronavirus

U.S. Health and Human Services (HHS) Secretary Alex Azar on Thursday said that at least 40 public health labs can currently test specimens for coronavirus and that could more than double as soon as tomorrow.

Azar, speaking before the House Ways and Means Committee, said the Centers for Disease Control and Prevention had tested 3,625 specimens for the fast-moving virus as of this morning. He said at least 40 labs currently have test kits that were previously manufactured by the CDC that were modified to test for coronavirus.

He said a newly manufactured CDC test can be sent to 93 public health labs as soon as Monday, and a privately manufactured test based on the new CDC test could be sent to those same labs as early as tomorrow, pending FDA clearance.

Feb. 27, 2020

https://www.usnews.com/

Read also

Phase 3 trials of treatment combo for hepatitis D expected in 2025

On the heels of positive Phase 2 clinical trial data, Vir Biotechnology is planning for the 2025 launch of a Phase 3 program, dubbed ECLIPSE, to test its treatment combination of tobevibart and elebsi...

Breakthrough Therapy Designation Market Is Booming Worldwide 2024-2032

The Breakthrough Therapy Designation market has witnessed significant growth over the past decade, driven by advancements in technology, shifting consumer preferences, and increasing investments from ...

Veeva Commercial Summit: Increased investment in medical affairs by pharma companies

Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scientific exchange between clinical experts and pharmaceutical companies.

Remix

Remix Therapeutics to Present Preclinical Data Demonstrating Anti-Leukemic Activity of REM-422 in AML at the 66th American Society of Hematology Annual Meeting and Exposition (ASH)